FDA Vape Regulations: The Struggle Between Market Access and Public Health The landscape of e-cigarette and nicotine pouch regulation in the United States is currently a high-stakes tug-of-war. On one …
Tag:
fda
-
-
Louisiana Urges Supreme Court to Block Nationwide Mailing of Abortion Pills A high-stakes legal battle over access to medication abortion has reached the U.S. Supreme Court. Louisiana state attorneys are …
-
The Pivot in Public Health: HHS and the Move Toward Cancer Vaccines The landscape of federal health priorities is undergoing a significant shift. The Department of Health and Human Services …
-
FDA Awards National Priority Vouchers to Psychedelic Drug Developers On April 24, 2026, the U.S. Food and Drug Administration (FDA) announced the issuance of three national priority vouchers to companies …
-
FDA Approves First Generic Versions of Farxiga (Dapagliflozin) In a significant move for patient access and healthcare affordability, the U.S. Food and Drug Administration (FDA) approved the first generic versions …
-
FDA Grants First Tentative Approval for Generic Ozempic In a significant move toward expanding affordable access to weight loss and diabetes medications, Apotex Corp. Has received the first U.S. Food …
-
FDA Approves Relacorilant Combination Therapy for Platinum-Resistant Ovarian Cancer On March 25, 2026, the Food and Drug Administration (FDA) approved relacorilant (Lifyorli, Corcept Therapeutics Inc.), a first-in-class selective glucocorticoid receptor …
-
New FDA Nutrition Labels: “High In” Warning Outperforms Current Proposal The U.S. Food and Drug Administration’s (FDA) proposed front-of-package (FOP) nutrition labeling system may not be the most effective way …
-
Children’s Ibuprofen Recall: What Parents Necessitate to Know Nearly 90,000 bottles of children’s ibuprofen oral suspension have been voluntarily recalled due to potential contamination with foreign substances, the U.S. Food …
-
FDA Faces Critical Juncture in Approving New Gene Therapies, Warns Former Commissioner Hundreds of individualized treatments for rare diseases could become available over the next decade, but their path to …
Newer Posts